Investigation on the Biosynthesis and Structural Diversity of Biarylitides Uncovers Novel Biosynthetic Paradigm
Investigation on the Biosynthesis and Structural Diversity of Biarylitides Uncovers Novel Biosynthetic Paradigm

dc.contributor.advisor | Crüsemann, Max | |
dc.contributor.author | Padva, Leo | |
dc.date.accessioned | 2025-09-11T13:21:36Z | |
dc.date.available | 2025-09-11T13:21:36Z | |
dc.date.issued | 11.09.2025 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11811/13440 | |
dc.description.abstract | Ribosomally synthesised and post-translationally modified peptides (RiPPs) constitute a major group of natural products. Biarylitides, a novel class of RiPPs first isolated from the bacterial genus Planomonospora, are biaryl-linked tripeptides synthesised by only two genes: bytA, which encodes a minimal five-amino acid precursor with a conserved MxYxH motif, and bytO, which encodes a cytochrome P450 monooxygenase (P450) that forms a C-C biaryl crosslink between the tyrosine and histidine aromatic side chains within the peptide. This thesis presents several advances in the understanding of biarylitide biosynthesis and diversity. A detailed characterisation of the BytO homologue P450Blt from Micromonospora sp. MW-13 unveiled a high degree of substrate flexibility, as well as selective formation of C-N crosslinks, even when tryptophan replaces the canonical histidine in the peptide substrate. Crystal structure analysis of P450Blt in complex with its substrate MRYLH identified key residues controlling substrate coordination and reaction specificity. The central discovery of this work revealed that rufomycin biosynthesis contains an unprecedented integration of ribosomal and non-ribosomal peptide pathways, thereby solving the mystery of nitrotyrosine formation. In this pathway, a biarylitide-like precursor peptide MRYLH undergoes selective tyrosine nitration catalysed by the BytO homologue RufO. Following proteolytic cleavage of the nitrated peptide, the released nitrotyrosine is incorporated by a non-ribosomal peptide synthetase to yield the potent antibiotic rufomycins. This neofunctionalised biarylitide machinery established a new paradigm for producing non-proteinogenic amino acids through RiPP pathways using peptides as templates. To explore the broader diversity of biarylitide systems in nature, machine learning-based genome mining was utilised to identify 124 new gene clusters and expanded the known class to 277 members, including two clusters in the human oral microbiome-associated Rothia species. Heterologous expression facilitated the characterisation of four novel biarylitides, including a putative hydroxylated YVH tripeptide. A novel BytO homologue subgroup was biochemically validated to catalyse crosslinking of atypical peptide motifs (MRYWY). Furthermore, nuclear magnetic resonance analysis of in vitro enzymatic products verified C-N crosslink formation in MKYWH peptides, enabling prediction of the final structure of this widespread bacterial natural product. Collectively, these findings have illuminated the remarkable diversity and evolutionary plasticity of biarylitide biosynthetic systems, creating new opportunities for natural product discovery and engineered peptide modifications. | en |
dc.language.iso | eng | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Ribosomale Peptide | |
dc.subject | Biarylitide | |
dc.subject | Cytochrom P450 | |
dc.subject | Naturstoffchemie | |
dc.subject | Rufomycin | |
dc.subject | Ribosomal peptides | |
dc.subject | Biarylitides | |
dc.subject | Cytochrome P450 | |
dc.subject | Natural products | |
dc.subject.ddc | 570 Biowissenschaften, Biologie | |
dc.subject.ddc | 615 Pharmakologie, Therapeutik | |
dc.title | Investigation on the Biosynthesis and Structural Diversity of Biarylitides Uncovers Novel Biosynthetic Paradigm | |
dc.type | Dissertation oder Habilitation | |
dc.publisher.name | Universitäts- und Landesbibliothek Bonn | |
dc.publisher.location | Bonn | |
dc.rights.accessRights | openAccess | |
dc.identifier.urn | https://nbn-resolving.org/urn:nbn:de:hbz:5-84922 | |
dc.relation.doi | https://doi.org/10.1016/j.chempr.2025.102438 | |
dc.relation.doi | https://doi.org/10.1002/cbic.202400916 | |
dc.relation.doi | https://doi.org/10.1002/chem.202400988 | |
dc.relation.doi | https://doi.org/10.1021/acscatal.3c05417 | |
dc.relation.doi | https://doi.org/10.1002/anie.202204957 | |
ulbbn.pubtype | Erstveröffentlichung | |
ulbbnediss.affiliation.name | Rheinische Friedrich-Wilhelms-Universität Bonn | |
ulbbnediss.affiliation.location | Bonn | |
ulbbnediss.thesis.level | Dissertation | |
ulbbnediss.dissID | 8492 | |
ulbbnediss.date.accepted | 08.09.2025 | |
ulbbnediss.institute | Mathematisch-Naturwissenschaftliche Fakultät : Fachgruppe Pharmazie / Pharmazeutische Biologie | |
ulbbnediss.fakultaet | Mathematisch-Naturwissenschaftliche Fakultät | |
dc.contributor.coReferee | Baunach, Martin | |
ulbbnediss.contributor.orcid | https://orcid.org/0000-0002-9850-6434 |
Dateien zu dieser Ressource
Das Dokument erscheint in:
-
E-Dissertationen (4378)